Kirby Seminar - Professor Miles Davenport -"Understanding host-pathogen interactions-from the molecule to the population."

Event date
Tuesday 23rd June 2015
Event time
1:00 PM
Event address
The Kirby Institute Level 6 Seminar Room Wallace Wurth Building UNSW Australia Sydney NSW 2052

Location:

The Kirby Institute Level 6 Seminar Room Wallace Wurth Building UNSW Australia Sydney NSW 2052

Open to

All

Contact for enquiries 

Rata Joseph +61 (0)2 9385 0900 rjoseph@kirby.unsw.edu.au

The Kirby Institute is pleased to present:

Professor Miles Davenport-  HEAD of Infection Analytics Program, Kirby Institute

"Understanding host-pathogen interactions-from the molecule to the population."

Abstract:
In an era of increasingly large and complex datasets, new analytical approaches are needed to understand and interpret this data and to integrate data across different scales. The Infection Analytics Program at the Kirby Institute uses analysis and modelling of experimental and clinical data to understand immune  control of infection, particularly in malaria and HIV. This work spans from the molecular scale - involving the bioinformatic analysis of the T cell receptor repertoire and HIV mutation and recombination rates - through to the population scale - modelling and analysis of infection rates in clinical cohorts. Professor Davenport will present an overview of the group's work, focusing on recent work using cohort data to understand immune  control of infection in malaria and viral latency in HIV infection.

Biography:
Professor Davenport received his medical degree from the University of Sydney, and completed his D.Phil in molecular immunology with Adrian Hill and Andrew McMichael at the University of Oxford. After completing this clinical and experimental training, he switched fields to apply a modelling approach to infection. He established and led the Complex Systems in Biology Group in the Centre for Vascular Research from 2003-2015, before moving to head the infection analytics program at the Kirby earlier this year. He collaborates with around 30 experimental and clinical groups worldwide, and has published over 160 papers in infection and immunity.